AUTOLOGOUS MESENCHYMAL STEM CELLS AS A NOVEL THERAPY FOR NO-OPTION CRITICAL LIMB ISCHEMIA: PRELIMINARY RESULTS OF A PHASE 1 STUDY

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume19
Publication statusPublished - 1 May 2017

Cite this